CT-guided percutaneous vertebral or paravertebral biopsy and aspiration is the diagnostic gold standard. If biopsy is available, polymerase chain reaction (PCR)-based technology such as GeneXpert might expedite the diagnostic process and allow the early recognition of antibiotic resistance.

Antituberculous therapy is the same as for pulmonary TB; however, most national guidelines and centres recommend longer treatment for nine instead of 6 months.